Apellis Pharmaceuticals

http://apellis.com/
Tags:DevelopmentPharmacy
Development of novel therapeutic compounds for autoimmune and inflammatory diseases. (NASDAQ: APLS)

Investors 3

Mentions in press and media 11

DateTitleDescriptionCategoryAuthorSource
11.06.2020What being...On March 14, at 10 a.m., I got...--statnews.c...
16.03.2020Two biotec...On Friday evening, Allogene CE...--medcitynew...
14.11.2017Epidarex C...Epidarex Capital, an early-sta...--citybizlis...
10.11.2017Term Sheet...HOT TAKES Happy Friday, Term ...--fortune.co...
31.10.2017Term Sheet...DEAD AND GONE Good morning, T...--fortune.co...
16.10.2017Term Sheet...MONDAY KICKOFF Good morning, ...--fortune.co...
10.08.2017Apellis Ph...Apellis Pharmaceuticals, Inc.,...USA-finsmes.co...
12.02.2016Apellis Ph...Apellis Pharmaceuticals, Inc.,...USA-finsmes.co...
02.12.2014Immunother...-COPD. Apellis thinks the same...--medcitynew...
05.04.2013Move over ...Bob Saunders, an angel investo...--medcitynew...
Show more